Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advanced technology for extracorporeal liver support system devices.

M Borra1, D Galavotti, C Bellini

  • 1RanD Biotech S.r.l., Medolla, Italy.

The International Journal of Artificial Organs
|November 29, 2002
PubMed
Summary

Extracorporeal Liver Support (ELS) offers a vital treatment for Acute Liver Failure (ALF) when transplants are unavailable. Combining artificial components within bioartificial systems shows promise for metabolic and detoxification support.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: <i>Lactiplantibacillus plantarum</i> HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis.

Food & function·2024
Same author

Determination of bioequivalence between generic and reference drugs using laser-induced breakdown spectroscopy.

Analytica chimica acta·2024
Same author

<i>Lactiplantibacillus plantarum</i> HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis.

Food & function·2024
Same author

Feasibility and Safety of the "One-Week Breast Radiation Therapy" Program.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Improved Measurement of Solar Neutrinos from the Carbon-Nitrogen-Oxygen Cycle by Borexino and Its Implications for the Standard Solar Model.

Physical review letters·2023
Same author

First Directional Measurement of Sub-MeV Solar Neutrinos with Borexino.

Physical review letters·2022

Area of Science:

  • Hepatology and Regenerative Medicine
  • Biomedical Engineering
  • Critical Care Medicine

Background:

  • Acute Liver Failure (ALF) is associated with high mortality, with liver transplantation as the primary effective treatment.
  • Liver transplantation is not always feasible due to donor scarcity or patient unsuitability.
  • Extracorporeal Liver Support (ELS) systems are emerging as a critical bridge therapy for ALF patients.

Purpose of the Study:

  • To review the development and efficacy of Extracorporeal Liver Support (ELS) systems for Acute Liver Failure (ALF).
  • To compare artificial and bioartificial ELS systems in managing liver metabolic and detoxification functions.
  • To highlight the potential of hybrid ELS approaches.

Main Methods:

  • Review of existing Extracorporeal Liver Support (ELS) technologies, including artificial (hemoperfusion, plasmaperfusion, TPE, continuous hemodialysis, HVCHF) and bioartificial systems.

Related Experiment Videos

  • Analysis of clinical trial data evaluating the performance of different ELS configurations.
  • Focus on systems utilizing hepatocytes within bioreactors for metabolic support.

    • Main Results:

    • Both artificial and bioartificial ELS systems aim to compensate for the liver's lost functions.
    • Bioartificial systems leverage biological components (hepatocytes) for metabolic activity and synthesis.
    • Clinical trials indicate that integrating artificial components into bioartificial circuits yields optimal results for metabolic compensation and detoxification.

    Conclusions:

    • Extracorporeal Liver Support (ELS) represents a significant advancement in managing Acute Liver Failure (ALF).
    • Hybrid ELS systems, combining artificial and biological elements, demonstrate superior efficacy in restoring liver function.
    • Further research and clinical application of optimized ELS are crucial for improving outcomes in ALF patients.